References
- Radic M, Pattanaik D. Thrombosis in COVID-19: A new challenge. Autoimmun Rev. 2023;22(4):103211. doi:10.1016/j.autrev.2023.103211
- Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033–2040. doi:10.1182/blood.2020006000.
- Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8(5):434–436. doi:10.1016/S2213-2600(20)30216-2
- Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570):eabd3876. doi:10.1126/scitranslmed.abd3876
- Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033– 1034. doi:10.1016/S0140-6736(20)30628-0
- Niu LL, Fan HL, Cao J, et al. Cardiovascular gene polymorphisms and homocysteine in deep vein thrombosis. ACS Omega. 2024;9:39836–39845. doi:10.1021/acsomega.4c05204
- Sanna G, Cuadrado MJ, D’Cruz DP, et al. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Rheum Dis Clin North Am. 2006 Aug;32(3):465–490. doi:10.1016/j.rdc.2006.05.010
- Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306. doi:10.1111/j.1538-7836.2006.01753.x
- Arachchillage DJ, Platton S, Hickey K, et al. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2024 Sep;205(3):855-880. doi:10.1111/bjh.19635
- Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296–1304. doi:10.1136/annrheumdis-2019-215213
- Pervez H, Rufus S, Gopalakrishnan P. In-situ coronary thrombosis in antiphospholipid syndrome: A case report. Cureus. 2019;11(9):e5727. doi:10.7759/cureus.5727
- Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease. Circulation. 2019;139(18):e891–e908. doi:10.1161/CIR.0000000000000670
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237–269. doi:10.1093/eurheartj/ehy462
- Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi:10.1093/eurheartj/ehad191.
- Khattab E, Karelas D, Pallas T, et al. MINOCA: A pathophysiological approach of diagnosis and treatment—A narrative review. Biomedicines. 2024;12(11):2457. doi:10.3390/biomedicines12112457